News

Genoskin awarded the Healthtech prize “Transformons la France!” Yesterday, Genoskin was awarded the Healthtech prize at the “Transformons la France!” (Let’s Transform France!) ceremony presented by La Tribune in Toulouse. While the current health crisis calls into question our lifestyles, "Transformons la France!" highlights the talents of tomorrow and gives impact to those who transform society for the better. TheRead more

Genoskin interviewed by the National Anti-Vivisection Society on alternatives to animal testing Genoskin’s Chief Commercial Officer, Eric Merle, recently had the opportunity to speak with the National Anti-Vivisection Society (NAVS). Through a Q&A, Eric explains why Genoskin’s ex vivo human skin assays are a reliable alternative to animal testing. “We generate human data” Even though testing new drugs and compoundsRead more

Genoskin & LEO Pharma publish data on inflammation model InflammaSkin® in Experimental Dermatology Genoskin’s amazing team of experts is always developing new and improved ex vivo human skin assays. This time, we partnered with LEO Pharma to develop a brand new inflammation model: InflammaSkin®. Genoskin is proud to announce that its unique skin assay is now fully described in ExperimentalRead more

Pharma's Almanac: Overcoming skin assays challenges with living human skin models Genoskin’s CEO, Pascal Descargues was asked to contribute to the next issue of Pharma’s Almanac. It’s increasingly critical for pharmaceutical companies to develop drugs faster and more efficiently. In this article, Pascal gives some insights into how living human skin models help accelerate research.  For decades, the norm forRead more

Genoskin launches new skin offering, NativeSkin® access, that increases accessibility to animal testing alternatives NativeSkin, the only ex vivo human skin model sold online, will be available to purchase daily at a key price point, making it easier to order even for larger volume sales Toulouse, France & Salem, MA, USA, September 1, 2020 - Genoskin, a biotechnology company developing ready-to-use human skinRead more

Genoskin in the News: article on Benzinga Benzinga biotech reporter Shanthi Rexaline recently spoke to GENOSKIN's CEO Pascal Descargues. In the interview, Pascal shared the inspiration behind founding Genoskin: Pascal quickly realized during his postdoctoral fellowship that animal models were not predictive enough. Pascal also had the opportunity to present Genoskin’s technology. He walked Shanthi through the Genoskin workflow: from sourcingRead more